Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeiQ’s synbiotic cleaning agents have demonstrated significant reductions in antimicrobial resistance genes such as MRSA mecA compared to standard disinfection methods. Their probiotic-based solutions have been validated by independent scientific studies at major hospitals and recommended by public health authorities as an adjunct to conventional hospital hygiene protocols. The company has secured major distribution agreements with global leaders like Ecolab for its life sciences products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeiQ.